| Authors: |
Lanteri MC; Creative Testing Solutions, Tempe, Arizona, USA.; University of California San Francisco, San Francisco, California, USA., Green V; Creative Testing Solutions, Tempe, Arizona, USA., Sulaeman H; Vitalant Research Institute, San Francisco, California, USA., Stone M; University of California San Francisco, San Francisco, California, USA.; Vitalant Research Institute, San Francisco, California, USA., Haynes J; American Red Cross, Rockville, Maryland, USA., Di Germanio C; University of California San Francisco, San Francisco, California, USA.; Vitalant Research Institute, San Francisco, California, USA., Smith S; Vitalant Research Institute, San Francisco, California, USA., Villaflor PG; Vitalant Research Institute, San Francisco, California, USA., Groves J; American Red Cross, Rockville, Maryland, USA., Williamson PC; Creative Testing Solutions, Tempe, Arizona, USA., Stramer SL; Infectious Disease Consultant, North Potomac, Maryland, USA., Coughlin MM; National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA., Jones JM; National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA., Grebe E; Vitalant Research Institute, San Francisco, California, USA., Busch MP; University of California San Francisco, San Francisco, California, USA.; Vitalant Research Institute, San Francisco, California, USA., Saa P; American Red Cross, Rockville, Maryland, USA.; Roche Diagnostics Solutions, Pleasanton, California, USA. |
